Turning bacteria into living transistors

 Bacteria x AI. Designed by Tim Sandle.

MIT researchers have created bacterial “transistors” that can be wired together into living circuits capable of performing calculations and directing chemical signals. One day, these biological computers could coat plant roots or leaves, detecting environmental threats and automatically triggering defences.

Article by Tim Sandle. 

Synthetic biology continues to push the boundaries of what living systems can accomplish. In the latest example of biological engineering, researchers from the Massachusetts Institute of Technology (MIT) have transformed bacteria into the equivalent of microscopic transistors, creating living circuits that can be arranged and connected in ways that resemble electronic circuit boards.

The breakthrough, published in Nature Chemical Biology (https://doi.org/10.1038/s41589-026-02300-3), represents a significant advance in biological computing. Rather than relying on silicon chips and electrical currents, the researchers use genetically engineered bacteria that communicate via chemical signals. The long-term aim is not to replace conventional computers but to create programmable biological systems capable of sensing, processing information and responding to their environment.

For microbiologists, the work demonstrates how microbial systems can be engineered into sophisticated information-processing networks. For biotechnology and pharmaceutical applications, it offers a glimpse of how living cells might one day perform complex monitoring and control functions in environmental, agricultural and potentially even healthcare settings.

From electronics to biology

Modern electronics are built around transistors, tiny switches that regulate the flow of electrical current. Transistors are the fundamental components from which logic gates, processors and ultimately computers are constructed.

The MIT team sought to create a biological equivalent. Instead of controlling electrical signals, the engineered microorganisms regulate the movement of small signalling molecules between bacterial populations. These molecules effectively act as information carriers, allowing one bacterial population to influence the behaviour of another.

The concept transforms individual bacterial colonies into functional computational units. By linking these biological components together, more sophisticated information-processing systems can be constructed.

According to lead author Hamid Doosthosseini, the research establishes a core set of biological building blocks that can be used in a modular fashion, much as electronic engineers assemble complex systems from standardised components.

 Bacterial circuits - designed by Tim Sandle.

The challenge of biological circuits

For more than two decades, synthetic biologists have been designing genetic circuits capable of performing logic operations inside cells. Such systems often rely on promoters, transcription factors and regulatory proteins that interact in carefully controlled ways.

These circuits have proven capable of detecting chemicals, responding to environmental signals and producing specific outputs. Applications have ranged from biosensors and diagnostics to engineered therapeutic organisms.

However, complexity has remained a major limitation.

According to reviews published in Nature Reviews Genetics and Cell Systems, biological circuits become increasingly difficult to engineer as the number of interacting components increases. Each additional transcription factor raises the possibility of unintended interactions and signal interference.

Furthermore, cells have finite biological resources. Introducing increasingly complex genetic programmes can place a significant burden on cellular metabolism and protein synthesis systems.

The MIT researchers addressed this challenge by dividing computational tasks across multiple bacterial populations rather than attempting to perform all functions within a single cell.

Engineering bacterial transistors

The researchers selected Pantoea agglomerans as their host organism. This Gram-negative bacterium is widely distributed in nature and is commonly associated with plant surfaces. P. agglomerans has attracted growing interest in biotechnology because of its environmental adaptability and ability to colonise plant tissues.

Two forms of bacterial transistor were engineered. One transistor activates when exposed to a signalling molecule known as OC6. The second functions in the opposite manner, switching off in response to the same molecule. Both transistor types also detect a second signalling compound, OC12. Depending on the combination of inputs received, the bacterial cells produce an output molecule designated OHC14.

In effect, each bacterial transistor operates as a biological logic component, converting environmental information into a chemical output that can be interpreted by other cells within the network.

Wiring living cells together

Creating functional biological circuits required more than isolated transistors. The MIT team engineered three additional strains of P. agglomerans that function as biological relays. These relay strains receive one chemical signal and convert it into another, enabling information transfer between different parts of the circuit. This arrangement allows bacterial populations to be connected in a manner analogous to electrical wiring.

Individual colonies were printed onto agar surfaces in carefully controlled spatial arrangements. Colonies were typically placed about five millimetres apart, ensuring chemical signals would diffuse primarily to neighbouring colonies. The physical layout effectively determines how information flows through the biological system.

This use of spatial organisation echoes approaches being explored elsewhere in microbial ecology and synthetic biology, where the arrangement of microbial communities can profoundly influence collective behaviour.

Building logic gates and computational functions

The researchers demonstrated that the bacterial transistors could be assembled into a variety of computational structures.

These included logic gates commonly used in conventional computing, such as OR and implication functions, together with multi-input processing systems.

More complex arrangements were also created.

One system functioned as a demultiplexer, a component that receives a single input and routes information towards different outputs depending upon a control signal. Such functions are routinely used in digital electronics but have been challenging to implement in living systems.

The largest biological circuit constructed during the study consisted of 24 interconnected bacterial colonies.

This network successfully performed addition operations using multiple inputs, illustrating that increasingly sophisticated computational tasks can emerge from combinations of relatively simple biological components.

Not replacing computers

The prospect of bacterial computers naturally invites comparisons with modern electronics.

Christopher Voigt, head of MIT's Department of Biological Engineering and senior author of the study, has noted that, in principle, the biological system could perform any computational function achievable by a conventional computer.

However, there is an obvious caveat.

Speed.

While modern processors perform billions of operations per second, the bacterial circuits require approximately eight hours to complete a single calculation. This reflects the time needed for microbial growth, protein expression and molecular diffusion.

For conventional computing, such speeds would be impractical. For biological systems, however, the timescale may be entirely acceptable.

Plant development, microbial colonisation and environmental responses often occur over hours, days or weeks. In such contexts, overnight computation may be perfectly adequate.

Implications for biotechnology

One of the most intriguing prospects is agricultural biotechnology.

The researchers envisage bacterial circuits being deployed on plant roots or leaves, where they could continuously monitor environmental signals such as nutrient availability, drought stress or pathogen attack.

Rather than simply detecting a condition, the biological circuit could process multiple inputs before generating an appropriate response.

For example, only when several stress indicators are detected simultaneously might the bacteria initiate production of a protective antimicrobial compound or activate a plant defence mechanism.

Such systems could eventually provide a form of biological decision-making that goes far beyond current biosensor technologies.

Implications for pharmaceutical microbiology

Although the work is currently focused on environmental and agricultural applications, the underlying concept may eventually hold significance for pharmaceutical microbiology.

Engineered microbial communities capable of processing multiple environmental inputs could potentially be applied to:

• Intelligent biosensing systems.
• Advanced environmental monitoring.
• Bioprocess control applications.
• Targeted microbial therapeutics.
• Smart probiotic platforms.

The ability to distribute computational functions across multiple microbial strains also reflects a broader trend within synthetic biology towards engineering microbial consortia rather than individual organisms.

As biological programming becomes increasingly sophisticated, living systems may become capable of performing functions that are currently impossible using traditional genetic engineering approaches.

While bacterial circuit boards are unlikely to replace silicon chips, they represent an important milestone in extending computation into the biological world. For microbiologists, the study demonstrates how microorganisms are evolving from mere production platforms into programmable information-processing systems, opening new possibilities for biotechnology, medicine and environmental science.

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

The Moon Is Not Sterile: What NASA's New Study Means for Microbial Contamination in Space Exploration

For decades, the Moon has been viewed as a largely lifeless and biologically inert environment. However, a fascinating new study from NASA suggests that some of Earth's microbial hitchhikers may be capable of surviving far longer on the lunar surface than previously imagined. The findings, published in Science Advances on 19 August 2026, have important implications not only for future lunar exploration but also for the broader field of planetary protection.

By Tim Sandle 

Humans Never Travel Alone

One of the fundamental realities of human spaceflight is that astronauts invariably carry microorganisms with them. The human body hosts vast microbial communities, with around one million bacteria occupying an area of skin roughly the size of a pencil eraser. No matter how carefully spacecraft, habitats, or spacesuits are designed, some microbes will inevitably escape into the surrounding environment.

As humanity prepares for a sustained presence on the Moon through programmes such as Artemis, this raises an important scientific question: how can we distinguish between native lunar chemistry and contamination introduced by human activity?

Planetary scientist Prabal Saxena, who led the NASA study, summed up the challenge succinctly. Human explorers bring their memories, tools, and technologies, but they also bring their microbiota. While this may complicate scientific investigations, it also offers a unique opportunity to study how terrestrial microorganisms respond to one of the harshest environments imaginable.

The South Pole: A Special Environment

The focus of the study was the Moon's South Pole, a region of enormous scientific interest. Unlike equatorial areas of the Moon, the polar regions receive sunlight at very shallow angles due to the Moon's minimal axial tilt.

This creates a complex patchwork of illuminated and permanently shadowed regions. Crater rims, ridges, and even relatively small topographical features can block sunlight, producing areas that remain extremely cold and protected from intense ultraviolet radiation. These permanently shadowed regions are already known to preserve water ice and other volatile compounds.

NASA researchers wondered whether these same environments might also provide refuges for microbes inadvertently deposited by astronauts.

Surprisingly Resilient Organisms

The study examined several microorganisms known to occur in human environments or in spacecraft-associated settings. These included Bacillus subtilis, Staphylococcus aureus, Deinococcus radiodurans, species of Fusarium, and the filamentous fungus Aspergillus niger.

For microbiologists, the inclusion of A. niger is particularly interesting. This ubiquitous environmental mould is commonly associated with soil, dust, HVAC systems, and damp indoor environments. It is not typically classified as an extremophile. Nevertheless, previous experiments have shown that it can survive exposure to the space environment, including conditions encountered outside the International Space Station.

Using published survival data, NASA researchers modelled the effects of temperature and ultraviolet radiation at several South Pole locations, including Nobile Rim, Connecting Ridge, and De Gerlache Rim. The results indicate that some Earth microorganisms could remain viable within small shadowed niches.

The most robust species was Aspergillus niger. Its resistance to ultraviolet radiation was sufficiently high that survival appeared possible even in locations receiving limited sunlight exposure, extending the range of potential microbial refuges.

Refuges No Larger Than a Footprint

Perhaps the most striking aspect of the study is the size of some survivable habitats. Researchers identified protected microenvironments ranging from large crater floors several kilometres wide down to spaces comparable in size to an astronaut's boot print.

These tiny refuges may provide sufficient protection from ultraviolet radiation and temperature extremes to allow microorganisms to remain viable for extended periods. Importantly, survival in this context simply means remaining alive. There is currently no evidence that any of these organisms could grow, divide, or establish self-sustaining populations on the Moon.

The absence of liquid water remains a critical limiting factor. Without accessible liquid water and a stable atmosphere, microbial replication is effectively impossible under current lunar conditions.

Lessons for Mars and Planetary Protection

The significance of these findings extends well beyond the Moon. Future missions to Mars will seek evidence of past or present extraterrestrial life. If Earth microorganisms can survive transport and persist in protected extraterrestrial environments, distinguishing indigenous biology from contamination becomes increasingly challenging.

This is why planetary protection remains such an important discipline. Understanding the baseline contamination introduced by human missions will help future scientists interpret biological and chemical signatures with greater confidence.

For microbial ecologists and astrobiologists, the Moon may become a valuable natural laboratory. Carefully monitored studies could reveal the true limits of microbial survival in environments that cannot be fully replicated on Earth.

What This Means for Microbiologists

Three key messages emerge from this research:

1. Microbial contamination is inevitable during human exploration. Even stringent contamination controls cannot completely eliminate microorganisms carried by astronauts and equipment.

2. Some common environmental fungi and bacteria are remarkably resilient. Organisms such as Aspergillus niger continue to challenge assumptions about the limits of microbial survival.

3. Planetary protection is becoming increasingly important. As humans establish a permanent presence beyond Earth, understanding and characterising microbial contamination will be essential for the integrity of future scientific investigations.

The Moon may not support microbial growth, but NASA's latest work demonstrates that it may not be as biologically sterile as once believed. For microbiologists, it is a reminder that life, even in its simplest forms, often proves more resilient than we expect.

The research has been published in Science Advances "Potential survivable niches for microbial life on the lunar south pole." 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Visualizing the Invisible: How 3D Mechanism Animation Helps Explain Microbial Contamination Pathways in Sterile Environments

 Image designed by Tim Sandle

Pharmaceutical microbiology has always faced a fundamental communication challenge: the phenomena it controls are, by definition, invisible to the unaided eye. Microbial particles, airborne contamination vectors, turbulent eddy currents that disrupt unidirectional airflow, and the trajectory of shed skin squames through a Grade A zone cannot be observed directly under routine manufacturing conditions. Historically, contamination control has relied on a combination of environmental monitoring data, smoke studies, risk assessments, and regulatory frameworks — all of which describe contamination pathways in the abstract rather than rendering them visible in mechanistic detail.

By Deepak Kumar

Three-dimensional mechanism animation is beginning to change this. Drawing on the same computational modelling methods used in fluid dynamics engineering and increasingly applied to pharmaceutical manufacturing, 3D animation offers a means of making microbial contamination pathways visible, spatially accurate, and cognitively accessible — to personnel, to quality teams, and to auditors — in ways that static diagrams or monitoring data tables cannot replicate.

The problem of invisible pathways in contamination control

The revised EU GMP Annex 1 (2022) makes the conceptual case for visualisation in contamination control more explicit than any prior regulatory framework. It requires that airflow visualisation studies be conducted in both static and dynamic conditions and documented through video recording, and it identifies personnel as a primary contamination vector requiring systematic behavioural and environmental controls. Its Contamination Control Strategy (CCS) framework further demands a holistic, science- and risk-based approach that integrates facility design, process understanding, and personnel practices.

This regulatory position reflects the microbiology: contamination in sterile pharmaceutical environments is not random. Peer-reviewed case analyses have consistently shown that in aseptic processing operations, Staphylococcus spp. and Micrococcus spp. predominate as cleanroom isolates, confirming that personnel shed — not equipment — remains the dominant contamination vector. Yet the mechanism by which shed microorganisms travel from the operator's surface to a critical zone is rarely communicated to cleanroom staff in a form that supports genuine understanding. Data on environmental monitoring excursions identifies that contamination occurred; it does not show operators how or why.

Environmental monitoring data identifies that contamination occurred. It does not show operators how or why — and that gap between detection and understanding is precisely where mechanism animation has a role to play.

What 3D mechanism animation can render that monitoring data cannot

Three-dimensional animation applied to pharmaceutical microbiology is not a substitute for validated environmental monitoring or airflow qualification — it is a complementary communication tool that makes the outputs of those processes spatially and mechanistically explicit. Several contamination phenomena are particularly suited to this format.

Airborne particle trajectories in controlled environments follow airflow physics that are already modelled computationally. Computational fluid dynamics (CFD) analysis is now routinely used in pharmaceutical cleanroom design to simulate airflow patterns, pressure differentials, particle distribution, and eddy formation before construction begins, providing engineering teams with three-dimensional visualisations that reveal contamination-prone zones that smoke tests cannot reliably detect in advance. The same three-dimensional output that validates a cleanroom HVAC design can, with appropriate adaptation, be used to show cleanroom personnel exactly how a disruption to first-air coverage propagates through a Grade A zone — making visible a phenomenon that is otherwise entirely conceptual.

Industry guidance on airflow visualisation studies explicitly notes that videos recorded during successful smoke studies, combined with practical simulations of common errors, serve as effective training resources — and that all operators should be required to review such material as part of the cleanroom qualification and entry process. Extending this principle into animated 3D mechanism sequences takes the same regulatory logic one step further: rather than recording a static smoke test in a finished cleanroom, a mechanistic animation can show the contamination consequence of any intervention error in any zone, under any set of conditions, repeatedly and without the logistical constraints of a physical smoke study.

The same approach applies to surface contamination pathways. The route by which a microorganism travels from an operator's gloved hand to a container closure — via a direct contact event, a droplet settling event, or an indirect surface touch sequence — is difficult to communicate through written standard operating procedures. An animated sequence showing the transfer mechanism, the role of contact pressure and dwell time, and the way barrier systems interrupt the pathway makes the contamination model spatially concrete rather than abstractly described.

Alignment with the Annex 1 contamination control framework

The Annex 1 CCS framework identifies personnel training and competency as a primary pillar of contamination prevention, requiring not merely instruction but competency-based assessment under realistic conditions. This creates a specific educational need that visual mechanism content is well positioned to address.

Contamination pathways in sterile manufacturing are not experienced intuitively by cleanroom operators. The consequences of an interrupted first-air zone, an ungloved surface contact, or a poorly sequenced door opening are invisible at the time they occur and may not appear in monitoring data until hours later — if they appear at all. An operator who understands spatially, through an animated mechanism sequence, how a single touch-transfer event creates a particle trajectory that reaches an open vial cannot rely solely on rule-following; they understand the risk in the same way a microbiologist understands it — through the mechanism itself.

This connects directly to what the revised Annex 1 describes as human reliability: the principle that procedural compliance is more robust when it is grounded in mechanistic understanding rather than rule memorisation. A PDA analysis of Annex 1 CCS implementation frames the Manpower branch of the CCS Ishikawa model in exactly these terms, identifying hygiene, training, gowning practices, and traceability of personnel working in aseptic zones as contamination risks that must be systematically identified and managed — a task that mechanism-level animation can support at the training and qualification stage.

Practical considerations and current limitations

Three-dimensional mechanism animation in this context is not without constraints. The accuracy of any animated contamination pathway depends on the fidelity of the underlying model — whether CFD-derived or constructed from first principles of particle physics and microbial dispersion — and any inaccuracy in the animation risks creating a false mental model in the learner, which is arguably worse than no visual at all. This places a methodological burden on the development process: animation of pharmaceutical contamination mechanisms must be built in collaboration with qualified microbiologists and contamination control specialists, not extrapolated from generic scientific graphics.

There is also the question of regulatory status. Three-dimensional mechanism animation, however accurate, does not constitute an airflow visualisation study for the purposes of Annex 1 qualification. It supplements, rather than replaces, the experimental and procedural work of contamination control strategy development. Its value is in closing the gap between what environmental monitoring programmes detect and what cleanroom personnel understand — a gap that, in the current regulatory environment, has measurable implications for both product quality and inspection outcomes.

Conclusion

Pharmaceutical microbiology operates in the space between the invisible and the measurable. Environmental monitoring and airflow qualification translate microbial risk into data; contamination control strategies translate data into controls. The step that is most difficult to systematise — the transfer of mechanistic understanding to the individuals operating within sterile environments — is also the step where visual communication has the greatest untapped potential. Three-dimensional mechanism animation is not a regulatory requirement and should not be treated as one. It is a pedagogical tool for making contamination pathways spatially explicit to the people most responsible for preventing them.

 

References

1. Microbial identification and contamination investigation in sterile drug manufacturing — PMC: pmc.ncbi.nlm.nih.gov/articles/PMC10895062/

2. Annex 1 CCS Implementation — PDA Letter: pda.org/pda-letter-portal/home/full-article/eu-gmp-annex-1.-implementation-of-contamination-control-strategy

3. Simulated cleanroom airflow visualisations / CFD in pharmaceutical design — CRB Group: crbgroup.com/insights/simulated-cleanroom-airflow-visualizations

4. Biggest sources of cleanroom contamination: Personnel — RSSL: rssl.com/insights/biggest-sources-of-cleanroom-contamination-personnel/

5. Review of Annex 1 (2022) Environmental Monitoring Changes — PMeasuring: br.pmeasuring.com/wp-content/uploads/2022/09/Review-of-Annex-1-2022.pdf

 

 

ABOUT AUTHOR

 

Deepak Kumar is a healthcare content writer with over 10 years of experience specializing in medical education, healthcare communication, and 3D medical animation. At Chasing Illusions Studio, he creates evidence-based content that simplifies complex medical concepts for healthcare professionals, patients, and life sciences organizations. His work supports global healthcare brands through accurate, engaging, and visually driven medical education.

 

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Conserving the Invisible Majority: Why Microbial Biodiversity Must Enter the Mainstream of Conservation

 

Conservation biology has traditionally focused on what can be seen: forests, coral reefs, mammals, birds and flowering plants. Yet the living systems that sustain those visible forms of life are, to a remarkable extent, microbial. Microorganisms regulate the major biogeochemical cycles, influence climate-relevant gas fluxes, underpin soil fertility, shape marine productivity and contribute fundamentally to the health of animals and plants, including humans. Despite this, microbes have remained largely peripheral to global conservation policy. That imbalance is now being challenged in a significant way through the creation of the International Union for Conservation of Nature (IUCN) Species Survival Commission’s Microbial Conservation Specialist Group (MCSG), approved in June and formally launched in 2025. 

By Tim Sandle 

The importance of this development should not be underestimated. The recent paper led by Jack Gilbert and colleagues in Sustainable Microbiology sets out what is, in effect, the first structured roadmap for microbial conservation. It argues that microorganisms are not a peripheral component of biodiversity, but its foundation. This is consistent with a growing body of literature that has warned that conservation frameworks have historically neglected microbes, even though microbial diversity and function are integral to ecosystem resilience, food security and planetary health. Redford and co-authors have previously made the case that conservation must be extended to include Earth’s microbiome, while broader assessments of soil biodiversity have reinforced how deeply microbial processes are tied to climate regulation, nutrient cycling and agricultural productivity. 

Understanding microbial community loss 

There is also a scientific reason why this agenda has arrived now. We are moving from a descriptive era of microbiology into one where microbial community loss, disruption and replacement can increasingly be observed and interpreted. In soils, aquatic systems and host-associated microbiomes, anthropogenic pressures including land-use change, pollution, industrialisation and climate change are altering microbial community structure and function. In human-associated microbiota, industrialised lifestyles have been associated with the erosion of microbial diversity and function, prompting the suggestion that microbiota science should borrow conceptual tools from macroecology and conservation. The microbial conservation agenda is therefore not speculative; it is a response to a mounting evidence base that the microbial biosphere is vulnerable and that losses can have ecological and health consequences.

What makes the MCSG especially noteworthy is that it moves the discussion from principle to programme. According to the roadmap, the group has assembled expertise from more than 30 countries and is structuring its work around the IUCN Species Conservation Cycle: assessment, planning, action, networking, and communication and policy. In practice, this means developing Red List-compatible tools for microbial communities, building ethical and economic frameworks for interventions, piloting field applications such as coral probiotics and soil microbiome restoration, connecting scientists with culture collections and custodians of microbial knowledge, and making microbial life visible in public and policy discourse. These are not abstract ambitions; they are mechanisms for embedding microbiology into mainstream biodiversity governance. 

Community integrity 

Of these elements, the assessment challenge is perhaps the most intellectually difficult. Traditional conservation tools were developed for discrete, named species with reasonably stable taxonomies and observable ranges. Microbial life seldom conforms to these assumptions. Species concepts are contested, taxonomies are dynamic, and the relevant unit of conservation may be an individual taxon, a functional guild, or a whole community. The MCSG’s proposed focus on “community integrity”, “functional collapse” and habitat specificity is therefore a pragmatic and scientifically mature response. It recognises that microbial conservation cannot simply replicate the plant-and-animal model; it must adapt conservation logic to the realities of microbial ecology.

There is also a second challenge: conservation is no longer only about what to protect, but how to intervene responsibly. The literature increasingly points to microbiome-based tools as active components of restoration, from coral probiotics to wildlife health interventions and soil carbon management. Raquel Peixoto’s work on coral probiotics is particularly relevant here, demonstrating that microbiology can support resilience and recovery rather than serving merely as a diagnostic science. Yet any move from observation to intervention demands governance. Microbial restoration, biobanking and engineered manipulation all require risk-benefit assessment, ecological caution and an explicit ethical framework. The MCSG seems to appreciate this point and is wise to treat planning and ethics as central, rather than secondary, pillars.

A further strength of the roadmap is its recognition that microbial conservation cannot be separated from questions of access, rights and knowledge. This is particularly important where human-associated or place-based microbiomes intersect with Indigenous communities. Recent scholarship has argued for relational frameworks for microbiome research, emphasising reciprocity, benefit-sharing and community-led oversight. Other authors have shown that Indigenous knowledge can broaden microbial science by placing microorganisms within ecological, cultural and land-based relationships rather than treating them purely as objects of extraction or technical intervention. If microbial conservation is to succeed, it must not reproduce the old extractive habits of science. The inclusion of Indigenous knowledge holders in the MCSG is therefore more than symbolic; it is a necessary condition for legitimacy.

Biobanking is central 

The biobanking dimension is equally important. Conservation requires baselines, archives and the ability to revisit what has been lost or changed. The MCSG’s intention to connect existing biobanks and culture collections into a coordinated global archive aligns with other emerging efforts, such as the Microbiota Vault initiative, which has argued that microbial ecosystems are fundamental to planetary and human health yet are being eroded by human activity. A global network of microbial archives will not solve the conservation problem by itself, but it does provide an infrastructure for surveillance, reference, restoration and research, particularly for undersampled environments such as deep oceans, aquifers, deserts and the cryosphere.

What, then, might success look like? In practical terms, it would mean that by the end of this decade microbial indicators are incorporated into biodiversity policy alongside plants and animals; that microbial hotspots are mapped and monitored; that national conservation strategies include soil, aquatic and host-associated microbial systems; and that One Health and climate frameworks recognise microbial ecology as foundational rather than incidental. It would also mean improving what might be termed public microbial literacy: recognising that microbes are not merely pathogens or laboratory curiosities, but the living infrastructure of ecosystems. This is the real conceptual shift. Microbial conservation asks us to move beyond charismatic biodiversity and towards process-based biodiversity—to conserve not only what life looks like, but how life works.

In this sense, the MCSG represents both a scientific advance and a philosophical one. It expands conservation from an emphasis on visible species to an appreciation of the invisible networks that make ecosystems functional and resilient. For microbiologists, that is a welcome and overdue reframing. For conservationists, it is a reminder that the biosphere cannot be protected if its microbial foundations remain ignored. And for policymakers, it is an invitation—perhaps a challenge—to build conservation frameworks that finally reflect biological reality. The invisible majority has been neglected for too long. Bringing it into policy is not an optional refinement; it is the next logical step in safeguarding planetary health.

See:  Safeguarding microbial biodiversity: microbial conservation specialist group within the species survival commission of the International Union for Conservation of Nature. Sustainable Microbiology, 2025; 2 (4) DOI: 10.1093/sumbio/qvaf024 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

Technological innovations in microbiology

The latest issue of Nature Microbiology contains a series ofinteresting articles on the progressive development of microbiological science. 

Among the highlights are:

High-throughoput metagenomics

A comprehensive comparative analysis by Treichel et al. showcases this strength and ability of high-throughput metagenomics in capturing strain-level bacterial diversity. Simultaneously, the authors warn about technical shortcomings related to sequencing depth and provide guidelines to circumnavigate them, highlighting the importance of careful oversight.  

Transcriptomic approaches 

A Review by Clatworthy et al. summarizes recent developments in bacterial single-cell transcriptomic approaches that provide high-resolution insights into bacterial heterogeneity and its physiological influence.

RNA sequencing 

Ntekas et al. combined single-cell RNA sequencing and microscopy to spatially resolve host–microorganism interactions associated with tumours along the mouse gut.  

Bacterial communities 

Moraïs et al. exploit high-throughput proteomics to uncover granular details on bacterial behaviour in simple and complex communities. It allowed them to quantitatively determine that bacteria respond to each other via modulation of their protein content to establish metabolic complementarity.

 

Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)